Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Non Small Cell Lung Cancer|Urothelial Carcinoma|Malignant Melanoma|Ovarian Cancer|Colorectal Cancer|Breast Cancer|Squamous Cell Carcinoma of the Head and Neck|Metastatic Cancer
Interventions: BIOLOGICAL: ARG1-18,19,20
Sponsor: Herlev Hospital